Hot Features
プレミアム
Roivant Sciences Ltd (ROIV)
NASDAQ
登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-05-20 | Dr. Eric VenkerPresident & CEO of Immunovant | -34.48k | 1.12M | Sale to Issuer | 32.41 | 1.36M | -2.47% |
| 2026-05-22 | Dr. Eric VenkerPresident & CEO of Immunovant | -200.00k | 5.28M | Derivative Exercise and Sale | 3.85 - 30.27 | 1.36M | - |
| 2026-05-20 | Mr. Richard PulikCFO | -18.96k | 614.56k | Sale to Issuer | 32.41 | 92.46k | -17.02% |
| 2026-04-20 | Dr. Eric VenkerPresident & CEO of Immunovant | -200.00k | 5.15M | Derivative Exercise and Sale | 3.85 - 29.59 | 1.33M | - |
| 2026-04-17 | Mr. Ilan OrenIndependent Chairman | -95.00 | 2.83k | Sale to Issuer | 29.83 | 105.71k | -0.09% |
| 2026-04-17 | Mr. James C. MomtazeeIndependent Director | -94.00 | 2.80k | Sale to Issuer | 29.83 | 94.88k | -0.10% |
| 2026-04-16 | Mr. Matthew GlineCEO & Director | -289.77k | 8.45M | 売り | 29.16 | 82.26k | -77.89% |
| 2026-04-08 | Ms. Jennifer HumesCAO | -13.54k | 384.07k | 売り | 28.37 | 84.19k | -13.85% |
| 2026-03-31 | Dr. Frank M. TortiPresident & Vant Chair | -160.04k | 4.43M | Sale to Issuer | 27.70 | 13.58M | -1.17% |
| 2026-03-30 | Mr. Matthew GlineCEO & Director | -97.32k | 2.63M | Derivative Exercise and Sale | 26.41 - 27.70 | 372.03k | - |
| 2026-03-31 | Mr. Matthew GlineCEO & Director | -261.19k | 7.23M | Sale to Issuer | 27.70 | 372.03k | -41.25% |
| 2026-03-30 | Dr. Mayukh SukhatmePresident, Chief Investment Officer & Director | -58.39k | 1.58M | Derivative Exercise and Sale | 26.41 - 27.70 | 18.68M | - |
| 2026-03-31 | Dr. Mayukh SukhatmePresident, Chief Investment Officer & Director | -158.93k | 4.40M | Sale to Issuer | 27.70 | 18.68M | -0.84% |
| 2026-03-26 | Ms. Meghan M. FitzGeraldIndependent Director | -70.00k | 1.31M | Derivative Exercise and Sale | 8.80 - 27.45 | 28.44k | - |
| 2026-03-20 | Mr. Richard PulikCFO | -1.55k | 42.82k | Sale to Issuer | 27.70 | 56.97k | -2.64% |
| 2026-03-20 | Ms. Jennifer HumesCAO | -14.53k | 402.37k | Sale to Issuer | 27.70 | 97.73k | -12.94% |
| 2026-03-17 | Dr. Eric VenkerPresident & CEO of Immunovant | -200.00k | 4.88M | Derivative Exercise and Sale | 3.85 - 28.24 | 1.33M | - |
| 2026-03-16 | Ms. Melissa B. EpperlyIndependent Director | -41.86k | 1.20M | 売り | 28.68 | 1.28k | -97.03% |
| 2026-02-20 | Mr. Richard PulikCFO | -1,000.00 | 27.15k | Sale to Issuer | 27.15 | 56.76k | -1.73% |
| 2026-02-20 | Dr. Eric VenkerPresident & CEO of Immunovant | -7.05k | 191.43k | Sale to Issuer | 27.15 | 1.33M | -0.53% |
| 2026-02-19 | Dr. Frank M. TortiPresident & Vant Chair | -3.00M | 70.49M | Derivative Exercise and Sale | 3.85 - 27.51 | 13.74M | - |
| 2026-02-13 | Dr. Eric VenkerPresident & CEO of Immunovant | -200.00k | 4.53M | Derivative Exercise and Sale | 3.85 - 26.49 | 1.33M | - |
| 2026-02-11 | QVT Financial LP法人 | -1.23M | 32.66M | 売り | 26.49 - 26.76 | 25.16M | -4.65% |
| 2026-02-09 | Dr. Mayukh SukhatmePresident, Chief Investment Officer & Director | -651.56k | 8.98M | Derivative Exercise and Sale | 12.68 - 26.47 | 18.84M | - |
| 2026-01-20 | Mr. Ilan OrenIndependent Chairman | -124.00 | 2.85k | Sale to Issuer | 22.98 | 104.90k | -0.12% |
| 2026-01-20 | Mr. James C. MomtazeeIndependent Director | -122.00 | 2.80k | Sale to Issuer | 22.98 | 94.51k | -0.13% |
| 2026-01-20 | Ms. Melissa B. EpperlyIndependent Director | -54.00 | 1.24k | Sale to Issuer | 22.98 | 43.14k | -0.13% |
| 2026-01-12 | Dr. Eric VenkerPresident & CEO of Immunovant | -200.00k | 3.61M | Derivative Exercise and Sale | 3.85 - 21.92 | 1.33M | - |
| 2025-12-29 | Dr. Mayukh SukhatmePresident, Chief Investment Officer & Director | -3.20M | 28.90M | Derivative Exercise and Sale | 12.68 - 21.74 | 18.84M | - |
| 2025-12-24 | Dr. Frank M. TortiPresident & Vant Chair | -175.38k | 1.46M | Other Disposition | 22.47 | 0.00 | -100.00% |
| 2025-12-23 | Dr. Eric VenkerPresident & CEO of Immunovant | 156.69k | 603.25k | Derivative Exercise and Retained Stock | 3.85 | 1.33M | 13.37% |
| 2025-12-23 | Dr. Eric VenkerPresident & CEO of Immunovant | -275.00k | 5.12M | Derivative Exercise and Sale | 3.85 - 22.53 | 1.33M | - |
| 2025-12-23 | Mr. Richard PulikCFO | -260.00k | 4.84M | Derivative Exercise and Sale | 3.85 - 22.45 | 52.92k | - |
| 2025-12-23 | Mr. Richard PulikCFO | -146.73k | 3.29M | 売り | 22.39 | 52.92k | -73.49% |
| 2025-12-20 | Mr. Richard PulikCFO | -2.13k | 47.71k | Sale to Issuer | 22.41 | 199.66k | -1.06% |
| 2025-12-17 | Dr. Mayukh SukhatmePresident, Chief Investment Officer & Director | -59.51k | 619.53k | Derivative Exercise and Sale | 12.68 - 23.09 | 0.00 | - |
| 2025-12-16 | QVT Financial LP法人 | -1.69M | 39.07M | 売り | 22.93 - 23.17 | 26.39M | -6.03% |
| 2025-12-15 | Mr. Matthew GlineCEO & Director | -3.87M | 36.85M | Derivative Exercise and Sale | 4.06 - 21.68 | 82.26k | - |
| 2025-12-11 | Mr. Vivek Ramaswamyインサイダー | -7.37M | 67.92M | Derivative Exercise and Sale | 12.68 - 22.05 | 47.01M | - |
| 2025-12-11 | Mr. Vivek Ramaswamyインサイダー | -1.00 | 21.64 | Other Disposition | 21.64 | 47.01M | -0.00% |
| 2025-12-09 | Dr. Eric VenkerPresident & CEO of Immunovant | -200.00k | 3.40M | Derivative Exercise and Sale | 3.85 - 20.85 | 1.17M | - |
| 2025-11-20 | Mr. Richard PulikCFO | -1.24k | 25.03k | Sale to Issuer | 20.27 | 197.62k | -0.62% |
| 2025-11-20 | Dr. Eric VenkerPresident & CEO of Immunovant | -7.05k | 142.92k | Sale to Issuer | 20.27 | 1.17M | -0.60% |
| 2025-11-19 | QVT Financial LP法人 | -1.30M | 26.30M | 売り | 20.16 - 20.25 | 28.08M | -4.42% |
| 2025-11-13 | Mr. Vivek Ramaswamyインサイダー | -1.85M | 37.94M | 売り | 20.33 - 20.81 | 47.01M | -3.80% |
| 2025-11-07 | Dr. Eric VenkerPresident & CEO of Immunovant | -200.00k | 3.27M | Derivative Exercise and Sale | 3.85 - 20.22 | 1.17M | - |
| 2025-10-20 | Mr. James C. MomtazeeIndependent Director | -158.00 | 2.80k | Sale to Issuer | 17.74 | 94.02k | -0.17% |
| 2025-10-20 | Mr. Ilan OrenIndependent Chairman | -281.00 | 4.98k | Sale to Issuer | 17.74 | 103.86k | -0.27% |
| 2025-10-15 | Dr. Eric VenkerPresident & CEO of Immunovant | -851.38k | 973.08k | Derivative Exercise and Sale | 15.85 - 17.06 | 1.17M | - |
| 2025-10-09 | Dr. Eric VenkerPresident & CEO of Immunovant | -125.67k | 55.51k | Derivative Exercise and Sale | 15.85 - 16.30 | 1.17M | - |
| 2025-10-06 | Dr. Eric VenkerPresident & CEO of Immunovant | -665.16k | 4.83M | Derivative Exercise and Sale | 3.85 - 16.34 | 1.17M | - |
| 2025-09-28 | Mr. Richard PulikCFO | -2.34k | 35.51k | Sale to Issuer | 15.17 | 196.43k | -1.18% |
| 2025-09-19 | Dr. Eric VenkerPresident & CEO of Immunovant | 1,000.00k | 3.85M | Derivative Exercise and Retained Stock | 3.85 | 1.17M | 601.34% |
| 2025-09-22 | Dr. Eric VenkerPresident & CEO of Immunovant | -562.37k | 6.24M | Derivative Exercise and Sale | 3.85 - 15.01 | 1.17M | - |
| 2025-09-19 | Dr. Eric VenkerPresident & CEO of Immunovant | -1.15M | 17.12M | 売り | 14.83 - 14.95 | 1.17M | -49.62% |
| 2025-09-20 | Mr. Richard PulikCFO | -2.13k | 32.02k | Sale to Issuer | 15.04 | 194.19k | -1.08% |
| 2025-09-18 | Mr. Matthew GlineCEO & Director | 3.32k | 49.96k | 買い | 15.07 | 62.47k | 5.60% |
| 2025-09-10 | Mr. Daniel A. GoldIndependent Director | -5.27k | 72.57k | Other Disposition | 13.77 | 8.95M | -0.06% |
| 2025-09-10 | Mr. James C. MomtazeeIndependent Director | -3.28k | 45.19k | Other Disposition | 13.77 | 93.39k | -3.40% |
| 2025-09-10 | Mr. Ilan OrenIndependent Chairman | -2.04k | 28.13k | Other Disposition | 13.77 | 102.64k | -1.95% |
| 2025-09-10 | Ms. Meghan M. FitzGeraldIndependent Director | -937.00 | 12.90k | Other Disposition | 13.77 | 28.44k | -3.19% |
| 2025-09-10 | Ms. Melissa B. EpperlyIndependent Director | -1.66k | 22.87k | Other Disposition | 13.77 | 41.32k | -3.86% |
| 2025-09-03 | Mr. Vivek Ramaswamyインサイダー | -1.78M | 22.46M | 売り | 12.50 - 12.96 | 48.87M | -3.51% |
| 2025-08-28 | Mr. Richard PulikCFO | -2.34k | 27.94k | Sale to Issuer | 11.94 | 192.15k | -1.20% |
| 2025-08-20 | Dr. Eric VenkerPresident & CEO of Immunovant | -100.00k | 787.00k | Derivative Exercise and Sale | 3.85 - 11.72 | 1.31M | - |
| 2025-08-20 | Dr. Eric VenkerPresident & CEO of Immunovant | -7.05k | 82.64k | Sale to Issuer | 11.72 | 1.31M | -0.53% |
| 2025-08-20 | Mr. Richard PulikCFO | -1.24k | 14.47k | Sale to Issuer | 11.72 | 192.32k | -0.64% |
| 2025-07-28 | Mr. Richard PulikCFO | -1.92k | 21.78k | Sale to Issuer | 11.35 | 191.14k | -0.99% |
| 2025-07-21 | Dr. Eric VenkerPresident & CEO of Immunovant | -100.00k | 767.00k | Derivative Exercise and Sale | 3.85 - 11.52 | 1.31M | - |
| 2025-07-17 | Mr. James C. MomtazeeIndependent Director | -241.00 | 2.81k | Sale to Issuer | 11.65 | 80.26k | -0.30% |
| 2025-04-17 | Mr. Ilan OrenIndependent Chairman | -115.00 | 1.34k | Sale to Issuer | 11.65 | 88.28k | -0.13% |
| 2025-06-28 | Mr. Richard PulikCFO | -1.65k | 18.83k | Sale to Issuer | 11.39 | 188.48k | -0.87% |
| 2025-06-25 | QVT Financial LP法人 | -36.76M | 0.00 | Other Disposition | - | 29.38M | -55.58% |
| 2025-06-20 | Mr. Richard PulikCFO | -1.50k | 17.21k | Sale to Issuer | 11.45 | 183.48k | -0.81% |
| 2025-06-20 | Dr. Eric VenkerPresident & CEO of Immunovant | -100.00k | 760.00k | Derivative Exercise and Sale | 3.85 - 11.45 | 1.31M | - |
| 2025-06-18 | Mr. Vivek Ramaswamyインサイダー | -1.14M | 13.08M | 売り | 11.45 - 11.46 | 50.64M | -2.21% |
| 2025-06-04 | Mr. Vivek Ramaswamyインサイダー | -748.23k | 8.45M | 売り | 11.19 - 11.34 | 51.78M | -1.42% |
| 2025-06-02 | Dr. Eric VenkerPresident & CEO of Immunovant | 385.03k | 1.48M | Derivative Exercise and Retained Stock | 3.85 | 1.31M | 41.66% |
| 2025-06-02 | Dr. Eric VenkerPresident & CEO of Immunovant | -1,000.00k | 7.30M | Derivative Exercise and Sale | 3.85 - 11.22 | 1.31M | - |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
メールアドレスで登録
すでにアカウントをお持ちですか？ サインイン
アカウントをお持ちでないですか？ 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。
